CPB Earnings

CPB reported its FY2026Q2 earnings on 2026-03-04, showcasing a revenue of against an estimate of 2.61B, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.56 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CPB's FY2026Q2 earnings announcement on 2026-03-04, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, CPB's stock price tends to shift by an average of +0.54% in the 10 days leading up to earnings and -1.25% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate CPB’s annual revenue to reach 2.62B, while the EPS is projected at 0.57. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.11% and EPS estimates Revise Downward by -1.23% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CPB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.11%, while EPS estimates moved Revise Downward by -1.23% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CPB's stock price typically moves by +0.54% in the 10 days before its earnings and -1.25% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.57 and revenue of 2.62B.

The earnings call reveals a decline in net sales for both Meals & Beverages and Snacks, driven by unfavorable volume/mix, despite favorable pricing. The Q&A highlights ongoing challenges in the Snacks segment and pressure on margins due to inflation and tariffs. While there are efforts to stabilize the Snacks segment and innovate, the guidance indicates declining EBIT and EPS. The La Regina acquisition is positive but not enough to offset broader concerns. Overall, the sentiment is negative, with potential stock price decline due to weak financial performance and guidance.